Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
Neuroscience Applied|July 14, 2025
Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacyBrian Dean, Elizabeth Scarr
Psychiatry Research|September 5, 2024
Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptorsMegan Snelleksz, Brian Dean
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 18, 2023
Common changes in rat cortical gene expression after valproate or lithium treatment particularly affect pre- and post-synaptic pathways that regulate four neurotransmitters systemsBrian Dean, Elizabeth Scarr
Psychiatry Research|July 13, 2006
Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorderLaura Gray, Elizabeth Scarr, Brian Dean
Schizophrenia Research|June 9, 2020
Higher levels of α7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophreniaBrian Dean, Geoffrey Pavey, Elizabeth Scarr
Schizophrenia Research|May 18, 2016
Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain BankBrian Dean, David Copolov, Elizabeth Scarr
Journal of Neural Transmission (Vienna, Austria : 1996)|October 1, 2016
Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's diseaseElizabeth Scarr, Catriona McLean, Brian Dean
Journal of Psychiatric Research|July 18, 2024
Changes in levels of the zinc transporter SLC39A12 in Brodmann's area 44: Effects of sex, suicide, CNS pH and schizophreniaBrian Dean, Shaun Hopper, Elizabeth Scarr
Schizophrenia Research|September 18, 2024
Lower levels of kainate receptors, but not AMPA or NMDA receptors, in Brodmann's area (BA) 9, but not BA 10, from a subgroup of people with schizophrenia who have a marked deficit in cortical muscarinic M1 receptorsMegan Snelleksz, Elizabeth Scarr, Brian Dean
Non-Coding RNA|August 28, 2020
Changes in Non-Coding RNA in Depression and Bipolar Disorder: Can They Be Used as Diagnostic or Theranostic Biomarkers?Andrew Gibbons, Suresh Sundram, Brian Dean
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Neuroscience Applied|July 14, 2025
Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacyBrian Dean, Elizabeth Scarr
Psychiatry Research|September 5, 2024
Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptorsMegan Snelleksz, Brian Dean
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 18, 2023
Common changes in rat cortical gene expression after valproate or lithium treatment particularly affect pre- and post-synaptic pathways that regulate four neurotransmitters systemsBrian Dean, Elizabeth Scarr
Psychiatry Research|July 13, 2006
Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorderLaura Gray, Elizabeth Scarr, Brian Dean
Schizophrenia Research|June 9, 2020
Higher levels of α7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophreniaBrian Dean, Geoffrey Pavey, Elizabeth Scarr
Schizophrenia Research|May 18, 2016
Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain BankBrian Dean, David Copolov, Elizabeth Scarr
Journal of Neural Transmission (Vienna, Austria : 1996)|October 1, 2016
Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's diseaseElizabeth Scarr, Catriona McLean, Brian Dean
Journal of Psychiatric Research|July 18, 2024
Changes in levels of the zinc transporter SLC39A12 in Brodmann's area 44: Effects of sex, suicide, CNS pH and schizophreniaBrian Dean, Shaun Hopper, Elizabeth Scarr
Schizophrenia Research|September 18, 2024
Lower levels of kainate receptors, but not AMPA or NMDA receptors, in Brodmann's area (BA) 9, but not BA 10, from a subgroup of people with schizophrenia who have a marked deficit in cortical muscarinic M1 receptorsMegan Snelleksz, Elizabeth Scarr, Brian Dean
Non-Coding RNA|August 28, 2020
Changes in Non-Coding RNA in Depression and Bipolar Disorder: Can They Be Used as Diagnostic or Theranostic Biomarkers?Andrew Gibbons, Suresh Sundram, Brian Dean
Pageof 25